Vivere Oncotherapies
Unlock the Full Potential of Cancer Immunotherapy
United States · $10.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- viveretx.com
- Total Funding
- $10.0M
- Last Round
- $10.0M SeedJan 2026
- Rounds
- 1
About
Biotech developing next-generation gene therapy and immunotherapy for cold solid tumors in oncology.
Summary
Vivere Oncotherapies is a Biotech company based in United States. It has raised $10.0M in total across 1 round, most recently a $10.0M Seed round in Jan 2026. Investors include YK Bioventures, Freeflow Ventures and Pillar VC.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2026
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vivere-oncotherapies"><img src="https://indexed.vc/api/badge/company/vivere-oncotherapies" alt="Vivere Oncotherapies on Indexed.vc" width="260" height="76" /></a>